SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	497.26M +112.6%
Revenue (ttm)	696.19M +7.3%
Net Income	16.68M +29.8%
EPS	2.03 +29.8%
Shares Out	8.22M
PE Ratio	29.81
Forward PE	n/a
Dividend	1.20 (2.00%)
Ex-Dividend Date	Apr 28, 2026

Volume	1,090
Average Volume	1,109
Open	60.00
Previous Close	60.00
Day's Range	60.00 - 60.50
52-Week Range	28.97 - 72.50
Beta	n/a
RSI	44.48
Earnings Date	May 21, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu...

• Founded: 1969
• Employees: 723
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2025, SALUS, Ljubljana, d. d.'s revenue was 696.19 million, an increase of 7.30% compared to the previous year's 648.83 million. Earnings were 16.68 million, an increase of 29.78%.